Comments on: A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Severe Sickle Cell Disease

Comments on: A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Severe Sickle Cell Disease https://scdstudies.com/a-phase-3-study-to-evaluate-the-safety-and-efficacy-of-a-single-dose-of-ctx001-in-pediatric-subjects-with-severe-sickle-cell-disease/?utm_source=rss&utm_medium=rss&utm_campaign=a-phase-3-study-to-evaluate-the-safety-and-efficacy-of-a-single-dose-of-ctx001-in-pediatric-subjects-with-severe-sickle-cell-disease Fri, 21 Jun 2024 12:15:24 +0000 hourly 1 https://wordpress.org/?v=6.7.1